Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
くすり.JP is a basic information website for prescription medicines provided by Nippon Boehringer Ingelheim Co., Ltd. It is not a general-purpose SaaS product, but a professional information portal for healthcare professionals in Japan. The site clearly states that its content is intended to provide detailed information on the company’s prescription medicines and is not aimed at the general public.
Based on the extracted text, the site includes modules such as product information, product lists, product lists by therapeutic area, expiration date search, online ordering of materials, and product FAQs. It also offers “Nippon Boehringer Ingelheim Medical Chat,” where users can ask general questions about the company’s pharmaceuticals and related topics via text. The chat service generally provides AI-generated responses, but users can switch to a human chat if desired. AI chat is available 24/7 year-round, while human chat is available on weekdays from 9:00 to 17:00.
The text does not disclose any fees, plans, or payment methods, so its commercial pricing model cannot be determined. Eligibility is strictly limited to healthcare professionals who handle the company’s pharmaceuticals and reside in Japan, including physicians, pharmacists, nurses, and other medical professionals. The service is available in Japanese only.
The advantages are its clear positioning and relatively comprehensive professional medical support portal, centered on drug information lookup, FAQs, expiration date searches, and material ordering. The AI chat is available around the clock and can be escalated to human support. Its compliance notices are also fairly clear: in principle, users are asked not to enter personal information such as names, addresses, phone numbers, or email addresses, although names and institution names may be requested for inquiries related to off-label use.
The limitations are that the service scope is narrow. It does not answer questions about specific symptoms or treatment methods, nor does it accept reports of side effects, product defects, or adverse events. Human support hours are limited, and the site does not disclose enterprise software capabilities such as third-party integrations, APIs, team permissions, audit features, or self-hosting.
It is suitable for healthcare professionals working in clinical practice, pharmacy, nursing, and related fields in Japan, for looking up basic information on Nippon Boehringer Ingelheim’s medicines in Japan and making general product inquiries. Access from mainland China is not mentioned in the text, so its availability is unknown.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on bij-kusuri.jp official site.
bij-kusuri.jp is an Japan Health provider. TG4G tracks its product information, an overall rating of 6.0/10, and a China-accessibility score of Limited (proxy recommended). Click "Visit Official Site" to reach bij-kusuri.jp directly.